T. Rowe Price Investment Management, Inc. Revolution Medicines, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 1,673,429 shares of RVMD stock, worth $67.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,673,429Holding current value
$67.3 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding RVMD
# of Institutions
303Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$668 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$544 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$539 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$474 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$410 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.53B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...